Results

1–10 of 328 results for Diabetic Retinopathy

Intraoperative Fluorescein Angiography to Efficiently Identify Many Biomarkers and Guide Surgical Decision-Making
Alan J. Franklin, MD, PhD
Annual Meeting Talks
2023
Cost-Effectiveness of Aflibercept Monotherapy vs Bevacizumab-First Followed by Switching to Aflibercept if Needed for Diabetic Macular Edema
Mathew W. MacCumber, MD, PhD
Annual Meeting Talks
2023
Impact of Initial Monthly Doses of Aflibercept on Visual Outcomes in Eyes With Diabetic Macular Edema in Routine Clinical Practice in the US
Ferhina S Ali, MD, MPH
Annual Meeting Talks
2023
Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: Week 48 Efficacy Outcomes by Baseline Demographics in the Phase 2/3 PHOTON Trial
Andres Emanuelli, MD
Annual Meeting Talks
2023
Aflibercept 8 mg for Diabetic Macular Edema: 2-Year Results of the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
Annual Meeting Talks
2023
Systemic Adverse Events in Patients With Diabetes Treated With Intravitreal Antivascular Endothelial Growth Factor Injections
Roomasa Channa, MD
Annual Meeting Talks
2023
National Cohort Study on New Oral Hypoglycemic Agents in Diabetic Retinopathy Progression
Ehsan Rahimy, MD
Annual Meeting Talks
2023
Retinal Nonperfusion on Widefield OCTA in Determining Diabetic Retinopathy Severity
Annual Meeting Talks
2023
Detection of Early Diabetic Retinopathy Using OCTA Bloodflow Analysis
Jennifer I. Lim, MD, FARVO, FASRS
Annual Meeting Talks
2023
Diabetic Retinopathy
JEFFERSON R SOUSA, Tecg.º (Biomedical Systems Technology)
Retina Image Bank: Images of the Week
2025